← Back to Search

Behavioral Intervention

Group Exposure Therapy for Social Anxiety (OASIS Trial)

N/A
Recruiting
Research Sponsored by University of Colorado, Boulder
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age between 18-30
Be between 18 and 65 years old
Must not have
Currently experiencing moderately severe or severe depression represented by the validated cutoff score for major depression on the PHQ-8 of greater than 14
Timeline
Screening 3 weeks
Treatment Varies
Follow Up between 0 and 10 days before the first intervention session, 48 hours after the final intervention session, and 1-month follow-up
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to study how different workshops can help with social anxiety and public speaking stress in University of Colorado Boulder undergraduate students. The study will last for about 8 weeks and involves completing questionnaires before

Who is the study for?
This trial is for University of Colorado Boulder undergraduates who experience social anxiety or stress related to public speaking. Participants will engage in an 8-week study involving questionnaires and weekly workshops.
What is being tested?
The study tests four types of group exposure therapy workshops aimed at reducing social anxiety, each with a different focus: self-compassion, peer support, or both. The effectiveness will be measured through questionnaires before and after the workshops and one month later.
What are the potential side effects?
Since this is a psychological intervention focusing on exposure therapy and not medication, side effects may include temporary increases in anxiety or discomfort during the process as participants face their fears.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 30 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently experiencing severe depression.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~between 0 and 10 days before the first intervention session, 48 hours after the final intervention session, and 1-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and between 0 and 10 days before the first intervention session, 48 hours after the final intervention session, and 1-month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability of Intervention Measure (AIM)
Attendance rate
Client Satisfaction Questionnaire-8 (CSQ-8)
+3 more
Secondary study objectives
Contamination
Enjoyableness
Fidelity
+10 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Peer enhancedExperimental Treatment1 Intervention
Group exposure therapy for social anxiety and public speaking fears facilitated by a pair of doctoral student and undergraduate student co-facilitators who will explicitly use appropriate self-disclosure to establish the co-facilitators as individuals with lived experiences of social anxiety and public speaking fears.
Group II: Fully enhancedExperimental Treatment1 Intervention
Group exposure therapy for social anxiety and public speaking fears plus self-compassion exercises aimed at inducing a sense of common humanity, facilitated by a pair of doctoral student and undergraduate student co-facilitators who will explicitly use appropriate self-disclosure to establish the co-facilitators as individuals with lived experiences of social anxiety and public speaking fears.
Group III: Compassion EnhancedExperimental Treatment1 Intervention
Group exposure therapy for social anxiety and public speaking fears plus self-compassion exercises aimed at inducing a sense of common humanity.
Group IV: Exposure OnlyActive Control1 Intervention
Group exposure therapy for social anxiety and public speaking fears.

Find a Location

Who is running the clinical trial?

University of Colorado, BoulderLead Sponsor
124 Previous Clinical Trials
29,221 Total Patients Enrolled
~120 spots leftby Oct 2025